Our Research

Discover our recent findings, catch up with news, and review in-depth resources and case studies.

Connect with Resolian at these upcoming events.

PERLs from Purification Resins in Biopharma | Resolian

PERLs from Purification Resins in Biopharma

What if your purification resin introduces impurities? Resolian’s multi-technique approach detects organic and inorganic PERLs from commercially available resins.
Read more
Ion-pair reagents contaminate systems and reduce sensitivity. Resolian's nSEC-MS method characterizes oligonucleotides in 7.5 minutes without ion-pairing agents.

Ion-Pair Free Oligonucleotide Analysis Using nSEC-MS

Ion-pair reagents contaminate systems and reduce sensitivity. Resolian’s nSEC-MS method characterizes oligonucleotides in 7.5 minutes without ion-pairing agents.
Read more
Developing and Validating a Simple, Rapid LC-MS/MS Method for Semaglutide in Human Plasma

Developing and Validating a Simple, Rapid LC-MS/MS Method for Semaglutide in Human Plasma

Discover how Resolian developed a validated LC-MS/MS method for semaglutide quantitation in human plasma, overcoming matrix effects and sensitivity challenges to support clinical trials.
Read more
Resolian Bioanalytics - Spectral Flow Cytometry

Spectral Flow Cytometry: From Trade-Offs to Total Clarity

Resolian combines the Cytek Aurora Full Spectrum Profiling platform with 25+ years of flow cytometry expertise to deliver complete immune clarity and confident, regulatory‑ready decisions for cell & gene therapy programs.
Read more
Overcoming Bioanalytical Challenges in siRNA Oligonucleotide Quantitation by LC-MS

Overcoming Bioanalytical Challenges in siRNA Oligonucleotide Quantitation by LC-MS

Turning Complexity into Clarity: Resolving siRNA Bioanalysis Challenges. How Resolian helps pharma and biotech partners overcome LC-MS hurdles for oligonucleotide quantitation.
Read more
Determination of Highly Polar Impurities in Drug Products

HPLC-UV Method Development for Highly Polar Impurities

Discover how Resolian developed and validated a GMP HPLC-UV method to achieve baseline resolution of highly polar impurities.
Read more
Scroll to Top

Nitrosamines

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Linkedin

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

 

Patrick Bennett

Chief Executive Officer

Linkedin

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.